Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNONW) Total Liabilities (2021 - 2025)

Historic Total Liabilities for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to $5.6 million.

  • Tenon Medical's Total Liabilities rose 1485.15% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 1485.15%. This contributed to the annual value of $3.9 million for FY2024, which is 3044.73% down from last year.
  • As of Q3 2025, Tenon Medical's Total Liabilities stood at $5.6 million, which was up 1485.15% from $4.4 million recorded in Q2 2025.
  • Tenon Medical's Total Liabilities' 5-year high stood at $16.2 million during Q1 2022, with a 5-year trough of $2.0 million in Q3 2022.
  • For the 5-year period, Tenon Medical's Total Liabilities averaged around $6.2 million, with its median value being $4.8 million (2022).
  • Per our database at Business Quant, Tenon Medical's Total Liabilities crashed by 7011.43% in 2022 and then surged by 19662.03% in 2023.
  • Tenon Medical's Total Liabilities (Quarter) stood at $16.2 million in 2021, then plummeted by 70.11% to $4.8 million in 2022, then grew by 15.09% to $5.6 million in 2023, then plummeted by 30.45% to $3.9 million in 2024, then skyrocketed by 43.8% to $5.6 million in 2025.
  • Its Total Liabilities stands at $5.6 million for Q3 2025, versus $4.4 million for Q2 2025 and $4.0 million for Q1 2025.